{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:33:44Z","timestamp":1769636024405,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier","isbn-type":[{"value":"9780443132841","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.pmbts.2023.11.007","type":"book-chapter","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T13:49:25Z","timestamp":1704376165000},"page":"45-66","source":"Crossref","is-referenced-by-count":9,"title":["SARS-CoV-2 variant biology and immune evasion"],"prefix":"10.1016","author":[{"given":"Asiya Kamber","family":"Zaidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan Bir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/bs.pmbts.2023.11.007_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib2","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1128\/JVI.00694-10","article-title":"Viral mutation rates","volume":"84","author":"Sanju\u00e1n","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/emph\/eoac010","article-title":"Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution","volume":"10","author":"Amicone","year":"2022","journal-title":"Evol. Med. Public. Health"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002881","article-title":"Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate","volume":"8","author":"Ribeiro","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12977-015-0180-6","article-title":"HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation","volume":"12","author":"Rawson","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1098\/rstb.2008.0185","article-title":"APOBEC proteins and intrinsic resistance to HIV-1 infection","volume":"364","author":"Malim","year":"2009","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/geno.2002.6718","article-title":"An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22","volume":"79","author":"Jarmuz","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib8","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.4161\/cc.4.9.1994","article-title":"APOBEC4, a new member of the AID\/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis","volume":"4","author":"Rogozin","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237689","article-title":"Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic","volume":"15","author":"Klimczak","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.11.007_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virol.2010.12.004","article-title":"Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral","volume":"411","author":"Samuel","year":"2011","journal-title":"Virology"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib11","doi-asserted-by":"crossref","first-page":"e00408","DOI":"10.1128\/mSphere.00408-20","article-title":"Rampant C\u2192U hypermutation in the genomes of SARS-CoV-2 and other coronaviruses: causes and consequences for their short- and long-term evolutionary trajectories","volume":"5","author":"Simmonds","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104351","article-title":"Emergence of genomic diversity and recurrent mutations in SARS-CoV-2","volume":"83","author":"van Dorp","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib13","doi-asserted-by":"crossref","first-page":"msac009","DOI":"10.1093\/molbev\/msac009","article-title":"Purifying selection determines the short-term time dependency of evolutionary rates in SARS-CoV-2 and pH1N1 influenza","volume":"39","author":"Ghafari","year":"2022","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib14","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1016\/j.cell.2021.08.014","article-title":"Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic","volume":"184","author":"Jackson","year":"2021","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib15","article-title":"Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations","author":"Rambaut","year":"2020","journal-title":"Virological"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib16","unstructured":"UK Health Security Agency (UKHSA), SARS-CoV-2 variants of concern and variants under investigation in England\u2014Technical Briefing39. GOV.UK. \u3008https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1063424\/Tech-Briefing-39\u201325March2022_FINAL.pdf\u3009, 2022."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib17","doi-asserted-by":"crossref","first-page":"eabg0821","DOI":"10.1126\/science.abg0821","article-title":"SARS-CoV-2 within-host diversity and transmission","volume":"372","author":"Lythgoe","year":"2021","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib19","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.chom.2022.10.003","article-title":"Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant","volume":"30","author":"Saito","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib20","article-title":"Convergent evolution of the SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant","author":"Ito","year":"2022","journal-title":"Prepr. bioRxiv"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib21","article-title":"Lineage replacement and evolution captured by the United Kingdom Covid Infection Survey","author":"Lythgoe","year":"2022","journal-title":"Prepr. medRxiv"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.11.007_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veac080","article-title":"The COVID-19 Genomics UK (COG-UK) Consortium, The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK","volume":"8","author":"Hill","year":"2022","journal-title":"Virus Evolution"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib23","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1126\/science.abj9932","article-title":"Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India","volume":"374","author":"Dhar","year":"2021","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-022-01911-2","article-title":"Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa","author":"Tegally","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2022.07.018","article-title":"Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron","author":"van der Straten","year":"2022","journal-title":"Immunity"},{"issue":"779\u2013784","key":"10.1016\/bs.pmbts.2023.11.007_bib26","article-title":"A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","volume":"78","author":"Hofmann","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib27","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41564-021-00908-w","article-title":"The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets","volume":"6","author":"Peacock","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41586-021-03237-4","article-title":"Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis","volume":"591","author":"Johnson","year":"2021","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103589","article-title":"Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike","volume":"25","author":"Lubinski","year":"2022","journal-title":"iScience"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib30","article-title":"SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway","author":"Willett","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib31","article-title":"SARS-CoV-2 spike engagement of ACE2 primes S2\u2032 site cleavage and fusion initiation","volume":"119","author":"Yu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib32","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.abl6184","article-title":"Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles","volume":"374","author":"Syed","year":"2021","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib33","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.chom.2021.11.005","article-title":"Nucleocapsid mutations R203K\/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2","volume":"29","author":"Wu","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib34","article-title":"Emergence of new subgenomic mRNAs in SARS-CoV-2","author":"Mears","year":"2022","journal-title":"Prepr. bioRxiv"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-04835-6","article-title":"The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle","author":"Ricciardi","year":"2022","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib36","article-title":"Enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants BA.4 and BA.5","author":"Reuschl","year":"2022","journal-title":"Prepr. bioRxiv"},{"key":"10.1016\/bs.pmbts.2023.11.007_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010349","article-title":"SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export","volume":"18","author":"Hall","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib38","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41423-020-0514-8","article-title":"SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70","volume":"17","author":"Jiang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib39","article-title":"Devil\u2019s tools: SARS-CoV-2 antagonists against innate immunity.","volume":"2","author":"Xu","year":"2021","journal-title":"Curr. Res. Virol. Sci."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41586-021-04245-0","article-title":"The N501Y spike substitution enhances SARS-CoV-2 infection and transmission","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"issue":"13","key":"10.1016\/bs.pmbts.2023.11.007_bib41","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.vaccine.2022.02.047","article-title":"The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals","volume":"40","author":"Uwamino","year":"2022","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.11.007_bib42","doi-asserted-by":"crossref","first-page":"8865","DOI":"10.1096\/fj.201802418R","article-title":"Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC","volume":"33","author":"Siu","year":"2019","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/bs.pmbts.2023.11.007_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/cei.13523","article-title":"Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage","volume":"202","author":"Amor","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2022.11.020","article-title":"Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches","volume":"156","author":"Ahmadi","year":"2023","journal-title":"Mol. Immunol."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib45","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1016\/j.csbj.2021.07.023","article-title":"Immune evasion of SARS-CoV-2 from interferon antiviral system","volume":"19","author":"Min","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"6","key":"10.1016\/bs.pmbts.2023.11.007_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167265","article-title":"Mechanisms of antiviral immune evasion of SARS-CoV-2","volume":"434","author":"Beyer","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3435","article-title":"OMICRON: virology, Immunopathogenesis, and laboratory diagnosis","author":"Bazargan","year":"2022","journal-title":"J. Gene Med."},{"key":"10.1016\/bs.pmbts.2023.11.007_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108536","article-title":"An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)","author":"Elahi","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/bs.pmbts.2023.11.007_bib49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41577-022-00715-2","article-title":"ORF9c and ORF10 as accessory proteins of SARS-CoV-2 in immune evasion","volume":"22","author":"Zandi","year":"2022","journal-title":"Nat. Rev. Immunol."}],"container-title":["Progress in Molecular Biology and Translational Science","Immunobiology of COVID-19"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117323001825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117323001825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T17:05:07Z","timestamp":1706375107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117323001825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443132841"],"references-count":49,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2023.11.007","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}